Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: tonyt who wrote (23796)	8/2/1998 9:05:00 PM
From: tonyt	Read Replies (1) \| Respond to of 32384

opps! that should be "I wonder why Barron's didn't mention LGND's pipeline." (don't want to be ticketed by the grammar police!)

To: tonyt who wrote (23796)	8/3/1998 2:31:00 AM
From: Robert L. Ray	Respond to of 32384

>>>I wonder Barron's didn't mention LGND's pipeline.<<< OH my God!!! Barrons mentioned 5 whole biotechs in an article and LGND wasn't one of them!!! I guess both me and the holders of 180+ other biotechs had better get on the phone to our brokers and bail out because obviously only those 5 mentioned are worth a damn.... NOT!!! It of course partly comes down to statistical probabilities, and like Bob Zagoran said.... The guy from Oracle Partners may possibly have self serving reasons for mentioning the stocks he did. Not that the companies mentioned weren't valid examples to make his point about biotechs in general. Sure it would have been nice if he had mentioned Ligand but he didn't.... Big whoop. Sequus I imagine will get a bit of a pop on the article in the morning but probably nothing lasting. Overall I liked the tone of the article very much. I've felt for a long time that it's very odd that the big pharmas haven't been doing more takeovers of biotech companies. I agree with him that if one or two significant takovers took place it would open the floodgates for more. It would seem to me that the big pharmas would go after the companies that had the best basic science platforms that they could build off of. At any rate the odds are always against being in a stock purely for any takeover reasons. That's not why I'm in LGND at all. Like someone else on the thread once said. LGND will either one day either fail or be worth billions. Personally I'm betting on billions. I'd love to see a few biotech takeovers whether LGND was one of them or not because it would help the stock prices of the whole sector. Internet companies which won't see profits for years and years (just like most biotechs) are being valued insanely high while the biotech sector languishes. There's such a thing in the market as a sector rotation. One of these days (if you or anyone else know the exact date please tell me:) the market will rotate to the biotechs and many of the Internet companies will be toast. A few takeovers would possibly be a nice catalyst. The whole sector could use some positive buzz to shift market psychology more in it's favor.